中文 | English
Return
Total: 174 , 1/18
Show Home Prev Next End page: GO
Author:(Jun Ho YI)

2.Novel combination immunochemotherapy beyond CD20 for B-cell lymphomas

Jun Ho YI

Blood Research 2021;56(S1):S1-S4

3.Novel combination immunochemotherapy beyond CD20 for B-cell lymphomas

Jun Ho YI

Blood Research 2021;56(S1):S1-S4

4.Epidemiology and Management of Iatrogenic Vertebral Artery Injury Associated With Cervical Spine Surgery

Ho Jun YI

Korean Journal of Neurotrauma 2022;18(1):34-44

6.Brentuximab vedotin: clinical updates and practical guidance.

Jun Ho YI ; Seok Jin KIM ; Won Seog KIM

Blood Research 2017;52(4):243-253

7.Response of Human Renal Cell Carcinoma Cells to Bone Morphogenetic Proteins, and the Expression of Bone Morphogenetic Protein Receptors.

Dong Hyeon LEE ; Jun Ho CHUNG ; Isaac Yi KIM

Korean Journal of Urology 2003;44(2):160-167

9.Prognostic significance of platelet-to-lymphocyte and platelet-to-neutrophil ratios in patients with mechanical thrombectomy for acute ischemic stroke

Seon-yeop KIM ; Ho Jun YI ; Dong-Seong SHIN ; Bum-Tae KIM

Journal of Cerebrovascular and Endovascular Neurosurgery 2022;24(3):221-231

10.Effectiveness of Anchoring with Balloon Guide Catheter and Stent Retriever in Difficult Mechanical Thrombectomy for Large Vessel Occlusion

Ho Jun YI ; Bum-Tae KIM ; Dong-Sung SHIN

Journal of Korean Neurosurgical Society 2022;65(4):514-522

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 174 , 1/18 Show Home Prev Next End page: GO